Reduced Expression of YAP in Dermal Fibroblasts is Associated with Impaired Wound Healing in Type 2 Diabetic Mice.
10.1007/s13770-016-0019-9
- Author:
Jinyeong YU
1
;
Sanghyuk CHOI
;
Jihyun UM
;
Ki Sook PARK
Author Information
1. Department of Genetic Engineering, Graduate School of Biotechnology, Kyung Hee University, Yong-In 17104, Korea.
- Publication Type:Original Article
- Keywords:
Dermal fibroblast;
Diabetes;
Wound;
YAP
- MeSH:
Animals;
Collagen;
Connective Tissue Growth Factor;
Cytokines;
Down-Regulation;
Extracellular Matrix;
Fibroblasts*;
Glucose;
In Vitro Techniques;
Intercellular Signaling Peptides and Proteins;
Mice*;
RNA, Messenger;
Wound Healing*;
Wounds and Injuries*
- From:
Tissue Engineering and Regenerative Medicine
2017;14(1):49-55
- CountryRepublic of Korea
- Language:English
-
Abstract:
Dermal fibroblasts play essential roles in wound healing and their dysfunction has been shown to be associated with impaired wound healing in diabetes. In the present study, we aimed at investigating whether Yes-associated protein (YAP), a mediator of mechanotransduction in dermal fibroblasts, is associated with impaired wound healing in diabetic mice. Compared with that in the control, the rate of wound contraction was decreased twofold in db/db type 2 diabetic mice (db/db mice). To mimic diabetic pathological condition, dermal fibroblasts were cultured under high glucose conditions (25.5 mM glucose). Further, dermal fibroblast-mediated contraction of wound was evaluated by in vitro collagen gel contraction assay. Dermal fibroblasts cultured under hyperglycemic condition showed impaired gel contraction and mitochondrial dysfunction, compared to the cells cultured under normoglycemic conditions (5.5 mM glucose). Importantly, compared with the normal dermal fibroblasts, diabetic db/db dermal fibroblasts expressed lower levels of growth factors and cytokines that enhance wound healing, such as insulin-like growth factor-1, stromal cell-derived factor-1, connective tissue growth factor, and transforming growth factor-β (TGF-β). The quantity of YAP mRNA was also lower in diabetic db/db dermal fibroblasts, compared with that in the control fibroblasts. These results indicate that impaired wound healing in diabetics is associated with the dysfunction of dermal fibroblasts, including downregulation of YAP, which plays essential roles in extracellular matrix remodeling and TGF-β-mediated wound healing.
